| Stage | KHC | % of rev | MDLZ | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $6.1B | 100.00% | $10.0B | 100.00% | MDLZ ×1.63 |
| Gross profit | $2.0B | 32.51% | $3.9B | 39.37% | MDLZ +6.9pp |
| Operating income | $875M | 14.31% | $1.8B | 17.64% | MDLZ +3.3pp |
| Pre-tax income | $704M | 11.51% | $1.7B | 17.27% | MDLZ +5.8pp |
| Net income | $536M | 8.77% | $1.3B | 13.12% | MDLZ +4.4pp |
| Stage | KHC | MDLZ | Gap · A − B |
|---|---|---|---|
| Revenue | $6.1B100.00% | $10.0B100.00% | MDLZ ×1.63 |
| Gross profit | 32.51%$2.0B | 39.37%$3.9B | MDLZ +6.9pp |
| Operating income | 14.31%$875M | 17.64%$1.8B | MDLZ +3.3pp |
| Pre-tax income | 11.51%$704M | 17.27%$1.7B | MDLZ +5.8pp |
| Net income |
| 8.77%$536M |
| 13.12%$1.3B |
| MDLZ +4.4pp |
No disclosed counterparties: MDLZ.
None